Escalon Medical Corp. (ESMC)

Market Cap	1.31M +18.1%
Revenue (ttm)	12.74M +5.7%
Net Income	2.01M +3,702.5%
EPS	0.27 +7,064.0%
Shares Out	7.42M
PE Ratio	0.65
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,200
Open	0.1771
Previous Close	0.1762
Day's Range	0.1771 - 0.1771
52-Week Range	0.1400 - 0.2850
Beta	0.57
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 14, 2026

About Escalon Medical

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachyme...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 40
• Stock Exchange: OTCMKTS
• Ticker Symbol: ESMC

Financial Performance

In fiscal year 2026, Escalon Medical's revenue was $12.74 million, an increase of 5.73% compared to the previous year's $12.05 million. Earnings were $2.01 million, an increase of 7062.83%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 3, 2026

Data Sources Report a data error